Objective: To conduct the Chinese cross-cultural adaptation of the Cochlear Implant Quality of Life-10 Global (CIQOL-10 Global) instrument.
Patients: Bilingual Chinese American cochlear implant users.
Intervention: Chinese cross-cultural adaptation of the CIQOL-10 Global.
Main Outcome Measure: Description of the process of Chinese cross-cultural adaptation of the CIQOL-10 Global and pilot testing of the Chinese CIQOL-10 Global in the target patient population.
Results: The CIQOL-10 Global was cross-culturally adapted into Chinese. Ten participants were recruited for pilot testing. There was wide representation from across the target population in terms of age (mean, 44.8 yr; range, 20.2-80.3 yr), sex (5 were male, 5 were female), education, and socioeconomic factors. All participants were able to easily read, comprehend, and fill out the Chinese CIQOL-10 Global.
Conclusions: The Chinese version of the CIQOL-10 Global is now available to provide an overall assessment of quality of life of Chinese-speaking cochlear implant users.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MAO.0000000000004005 | DOI Listing |
Otol Neurotol
July 2024
Department of Otolaryngology-Head & Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Objectives: To investigate the quality of life (QOL) of adult Mandarin-speaking Chinese Americans after cochlear implantation (CI) using the cross-culturally adapted Chinese Cochlear Implant Quality of Life-10 (CIQOL-10) Global.
Study Design: Cross-sectional.
Setting: Tertiary care neurotology practice in New York City.
Ann Otol Rhinol Laryngol
May 2024
Department of Otolaryngology-Head and Neck Surgery, University of California-Davis, Sacramento, CA, USA.
Objectives: There is a limited understanding of the impact of cochlear implantation (CI) in patients with Charcot-Marie-Tooth disease (CMT), given the scarcity of reported cases. We aim to evaluate the audiological outcomes and quality of life (QoL) after CI in CMT.
Methods: Multi-institutional, university-affiliated, tertiary-referral centers, retrospective chart review.
Otol Neurotol
December 2023
Department of Otolaryngology-Head and Neck Surgery.
Objective: To study the relationship between Cochlear Implant Quality of Life-10 Global (CIQOL-10) scores and speech recognition scores 6 and 12 months after cochlear implantation (CI) and to compare CIQOL-10 scores for patients who met the benchmark speech recognition scores with those who did not.
Study Design: Retrospective review.
Setting: Tertiary referral center.
Otol Neurotol
October 2023
Department of Otolaryngology-Head & Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Laryngoscope
September 2023
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Objective: To report our experience for adults undergoing cochlear implantation (CI) for single-sided deafness (SSD).
Methods: This is a retrospective case series for adults with SSD who underwent CI between January 2013 and May 2021 at our institution. CNC and AzBio speech recognition scores, Tinnitus Handicap Inventory (THI), Speech, Spatial, and Qualities of Hearing Scale (SSQ12), datalogging, and the Cochlear Implant Quality of Life (CIQOL)-10 Global measure were utilized.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!